Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation

Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) has scheduled its third quarter 2024 business performance presentation and Q&A session for Tuesday, November 12, 2024, at 5:30 p.m. ET, after market close. The presentation will cover results for the quarter ended September 30, 2024. Investors can access the webcast through Ginkgo's investor relations website, where a replay will also be available. Questions can be submitted beforehand via X (using #GinkgoResults) or email.

News Market Reaction – DNA

+4.72%

+4.72% Session move

In the trading session that priced this news, DNA gained 4.72%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Presentation and Q&A session scheduled for post-market on Tuesday, November 12, 2024

BOSTON, Nov. 5, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2024, on Tuesday, November 12, 2024, beginning at 5:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.  For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com     

MEDIA CONTACT:

press@ginkgobioworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-third-quarter-2024-results-presentation-302295611.html

SOURCE Ginkgo Bioworks

FAQ

When will Ginkgo Bioworks (DNA) release Q3 2024 earnings?

Ginkgo Bioworks will release its Q3 2024 earnings on Tuesday, November 12, 2024, at 5:30 p.m. ET, after market close.

How can I access Ginkgo Bioworks (DNA) Q3 2024 earnings call?

The earnings presentation can be accessed through Ginkgo's investor relations website at investors.ginkgobioworks.com, where a replay will also be available.

How can investors submit questions for Ginkgo Bioworks (DNA) Q3 2024 earnings call?

Investors can submit questions either through X (using #GinkgoResults) or by sending an email to investors@ginkgobioworks.com.